Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy

被引：0

作者：

J. De Castro

J. L. González-Larriba

S. Vázquez

B. Massutí

J. M. Sanchez-Torres

M. Dómine

P. Garrido

A. Calles

A. Artal

R. Collado

R. García

M. Sereno

M. Majem

J. A. Macías

O. Juan

J. Gómez-Codina

B. Hernández

M. Lázaro

A. L. Ortega

M. Cobo

J. M. Trigo

E. Carcereny

C. Rolfo

S. Macia

J. Muñoz

P. Diz

M. Méndez

F. Rosillo

L. Paz-Ares

J. V. Cardona

D. Isla

机构：

[1] Hospital Universitario La Paz-IDIPAZ,Medical Oncology Unit––Department of Translational Oncology

[2] Hospital Clínico Universitario San Carlos,undefined

[3] Hospital Universitario Lucus Augusti,undefined

[4] Hospital General Universitario de Alicante,undefined

[5] MD Anderson Cancer Center Madrid,undefined

[6] Fundación Jiménez Díaz,undefined

[7] Hospital Ramón y Cajal,undefined

[8] Centro Integral Oncológico Clara Campal,undefined

[9] Hospital Universitario Miguel Servet,undefined

[10] Hospital San Pedro de Alcántara,undefined

[11] Hospital Universitario Gregorio Marañón,undefined

[12] Hospital Infanta Sofía,undefined

[13] Hospital de la Santa Creu i Sant Pau,undefined

[14] Hospital General Universitario Morales Meseguer,undefined

[15] Hospital Arnau Vilanova,undefined

[16] Hospital La Fe,undefined

[17] Complejo Hospitalario de Navarra––Hospital de Navarra,undefined

[18] Complexo Hospitalario Universitario de Vigo,undefined

[19] Complejo Hospitalario de Jaén,undefined

[20] Hospital Regional Universitario Carlos Haya,undefined

[21] Hospital Universitario Virgen de la Victoria,undefined

[22] Institut Català d’Oncologia-Hospital Universitari Germans Trias i Pujol,undefined

[23] University Hospital of Antwerp,undefined

[24] Hospital General Universitario de Elda,undefined

[25] Hospital Universitario Doctor Peset,undefined

[26] Complejo Asistencial Universitario de León,undefined

[27] Hospital Universitario de Móstoles,undefined

[28] Complejo Hospitalario Torrecárdenas,undefined

[29] Hospital Universitario Virgen del Rocío,undefined

[30] Roche Farma,undefined

[31] S.A.,undefined

[32] Hospital Clínico Universitario Lozano Blesa,undefined

来源：

Clinical and Translational Oncology | 2017年 / 19卷

关键词：

Non-squamous NSCLC; First-line treatment; Bevacizumab; Bevacizumab maintenance therapy; Routine clinical practice setting; Observational study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：219 / 226

页数：7

共 50 条

[41] First-line Atezolizumab plus Bevacizumab for Metastatic High-Intermediate TMB in Non-squamous NSCLC. The TELMA Study
Provencio-pulla, M.
Ortega, A. L.
Coves, J.
Franco, F.
Marse, R.
Domine, M.
Guirado, M.
Carcereny, E.
Fernandez, N.
Martinez, E.
Blanco, R.
Leon, L.
Sanchez, J. M.
Sullivan, I.
Cobo, M.
Sanchez, A.
Massuti, B.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S123 - S124
[42] First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naive patients
Leon, Luis
Vazquez, Sergio
Manuel Gracia, Jose
Casal, Joaquin
Lazaro, Martin
Luis Firvida, Jose
Amenedo, Margarita
Santome, Lucia
Macia, Sonia
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (10) : 1389 - 1396
[43] A phase II first-line study of gemcitabine, carboplatin, and bevacizumab (GCB) in advanced (adv) stage non-squamous non-small cell lung cancer (NSCLC)
Krupitskaya, Y.
Ganjoo, K.
Lavori, P. W.
Kumar, A.
Clement-Duchene, C.
Zhao, G.
Padda, S.
San Pedro-Salcedo, M.
Wakelee, H. A.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[44] Bevacizumab plus chemotherapy extends survival of patients with first-line nonsquamous NSCLC
不详
ONCOLOGY-NEW YORK, 2005, 19 (04): : 473 - 473
[45] EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung Cancer
De Marinis, Filippo
Bidoli, Paolo
Luciani, Andrea
Amoroso, Domenico
Tonini, Giuseppe
Bertolini, Alessandro
Brandes, Alba A.
Migliorino, Maria Rita
Favaretto, Adolfo
Gridelli, Cesare
ANTICANCER RESEARCH, 2017, 37 (05) : 2457 - 2464
[46] Maintenance Therapy in advanced non-squamous NSCLC With Pemetrexed a Survival Advantage can be achieved
不详
ONKOLOGIE, 2012, 35 (09):
[47] Impact of Depth of Response (DpR) on Survival in Patients with Advanced NSCLC Treated with First-Line Chemotherapy
Morgensztern, Daniel
O'Brien, Mary
Ong, Teng
Socinski, Mark
Postmus, Pieter
Ko, Amy
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S387 - S388
[48] Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line?
Adderley, Helen
Ackermann, Christoph Jakob
Califano, Raffaele
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
[49] TULUNG REGISTRY: Data Analysis of Patients with Non-Squamous NSCLC Treated with Bevacizumab in the Czech Republic
Havel, Libor
Krejci, Jana
Hejduk, Karel
Skrickova, Jana
Tomiskova, Marcela
Coupkova, Helena
Salajka, Frantisek
Hrnciarik, Michal
Kolek, Vitezslav
Grygarkova, Ivona
Roubec, Jaromir
Pesek, Milos
Zemanova, Milada
Koubkova, Leona
Cernovska, Marketa
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S546 - S546
[50] BO17704: a phase III study of first-line cisplatin and gemcitabine with bevacizumab or placebo in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)
Reck, Martin
von Pawel, Joachim
Zatloukal, Petr
Ramlau, Rodryg
Gorbounova, Vera
Hirsh, Vera
Leighl, Natasha
Mezger, Joerg
Archer, Venice
Manegold, Christian
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S360 - S361

← 1 2 3 4 5 →